| Original language | English |
|---|---|
| Journal | The Lancet Oncology |
| Volume | 13 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Apr 2012 |
ASJC Scopus subject areas
- Oncology
Cite this
Lorusso, V., & Cinieri, S. (2012). Second-line erlotinib for non-small-cell lung cancer. The Lancet Oncology, 13(4). https://doi.org/10.1016/S1470-2045(12)70113-4
Second-line erlotinib for non-small-cell lung cancer. / Lorusso, Vito; Cinieri, Saverio.
In: The Lancet Oncology, Vol. 13, No. 4, 04.2012.Research output: Contribution to journal › Article
Lorusso, V & Cinieri, S 2012, 'Second-line erlotinib for non-small-cell lung cancer', The Lancet Oncology, vol. 13, no. 4. https://doi.org/10.1016/S1470-2045(12)70113-4
Lorusso V, Cinieri S. Second-line erlotinib for non-small-cell lung cancer. The Lancet Oncology. 2012 Apr;13(4). https://doi.org/10.1016/S1470-2045(12)70113-4
@article{9701749f639b4d71b3c131246c4ad62b,
title = "Second-line erlotinib for non-small-cell lung cancer",
author = "Vito Lorusso and Saverio Cinieri",
year = "2012",
month = "4",
doi = "10.1016/S1470-2045(12)70113-4",
language = "English",
volume = "13",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "4",
}
TY - JOUR
T1 - Second-line erlotinib for non-small-cell lung cancer
AU - Lorusso, Vito
AU - Cinieri, Saverio
PY - 2012/4
Y1 - 2012/4
UR - http://www.scopus.com/inward/record.url?scp=84859134673&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859134673&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(12)70113-4
DO - 10.1016/S1470-2045(12)70113-4
M3 - Article
C2 - 22469123
AN - SCOPUS:84859134673
VL - 13
JO - The Lancet Oncology
JF - The Lancet Oncology
SN - 1470-2045
IS - 4
ER -